1989

August
  • BIOTON Sp. z o.o. is entered into Commercial Register B.

1993

June
  • BIOTON Sp. z o.o. commences operations by purchasing raw materials to produce cephalosporins for injective administration and selling their pharmaceutical forms.

1996

March
  • Prokom Investments S.A. acquires a shareholding in BIOTON Sp. z o.o.
October
  • BIOTON acquires BIOTON BIS Sp. z o.o. and transforms it into a Bioton Production Plant.

1997

July
  • BIOTON acquires BIOTON PRIM Sp. z o.o. in Macierzysz and transforms it into Production Plant no. I.

1998

July
  • BIOTON incorporates BIOTON TRADE Sp. z o.o., a subsidiary in Macierzysz responsible for the Company's commercial affairs.
  • BIOTON acquires BIOLEK Sp. z o.o. in Duchnice and transforms it into a Bioton Production Plant.

1999

June
  • The plant in Macierzysz acquires a GMP certificate.
  • The central warehouse in Duchnice opens.
July
  • The central warehouse in Duchnice opens.
December
  • The 17 Gensulin series products, the world's fourth recombinant human insulin products, are registered in Poland.

2001

January
  • BIOTON acquires IBATECH Sp. z o.o. in Macierzysz and transforms it into Bioton's Biotechnology Division.
May
  • BIOTON launches the sale of human insulin in Poland.

2004

August
  • BIOTON Sp. z o.o. is transformed into BIOTON S.A., a joint-stock company.
December
  • BIOTON and its Russian partners incorporate ZAO BIOTON WOSTOK in the Russian Federation.

2005

January
  • BIOTON begins acquiring shares in Singapore's SciGen Ltd.
March
  • BIOTON S.A. debuts on the Warsaw Stock Exchange becoming Poland's first listed biotechnological company.
November
  • BIOTON and its Russian and Kazakh partners incorporate BIOTON-ASIA TOO in Kazakhstan.

2006

March
  • BIOTON begins acquiring shares in Ukraine's ZAO INDAR.
June
  • BIOTON incorporates Hefei-SciGen-Bioton Biopharmaceutical Company Ltd. in China.

2007

March
  • BIOTON takes over BioPartners Holdings AG of Switzerland.
September
  • BIOTON finalises negotiations to take-over Italian companies Pharmatex Italia S.R.L. and Fisiopharma S.R.L.

2008

February
  • Acquiring the Italian companies Pharmatex Italia S.R.L. and Fisiopharma S.R.L.
  • Finalising the transaction to set up the M.J. Bioton Life Sciences Ltd joint-venture, in which BIOTON has a 50% stake.

Bioton WorldWide

Requires the Flash plugin. If the plugin is already installed, click here.

GPW

Press Contact

Contact for media:

Kinga Fromlewicz

kfromlewicz@egzogroup.pl

Mobile: +48 506 025 066

 

Contact for investors:

Grzegorz Kubica

gkubica@egzogroup.pl 

Mobile: +48 663 307 503